Heart Historical Income Statement

HSCS Stock

USD 3.81 0.00 0.00%

Historical analysis of Heart Test income statement accounts such as Selling General Administrative of 2.5 M or Total Revenue of 20.5 K can show how well Heart Test Laboratories performed in making a profits. Evaluating Heart Test income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Heart Test's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Heart Test Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Heart Test Laboratories is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heart Test Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

About Heart Income Statement Analysis

Heart Test Laboratories Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Heart Test shareholders. The income statement also shows Heart investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Heart Test Income Statement Chart

At this time, Heart Test's Total Revenue is comparatively stable compared to the past year. Cost Of Revenue is likely to gain to about 11.8 K in 2024, despite the fact that Net Interest Income is likely to grow to (336.4 K).

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Reconciled Depreciation

Total Revenue

Total revenue comprises all receipts Heart Test Laboratories generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Heart Test Laboratories minus its cost of goods sold. It is profit before Heart Test operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Heart Test Laboratories. It is also known as Heart Test overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Heart Test's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Heart Test Laboratories current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heart Test Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

	2021	2022	2023	2024 (projected)
Interest Expense	371.6K	243.2K	354.1K	242.9K
Depreciation And Amortization	26.6K	26.9K	95.1K	58.5K

Interest Expense Depreciation And Amortization

Heart Test income statement Correlations

	Net Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense
Net Interest Income		0.59	-0.99	-0.56	0.93	0.85	-0.72	0.78	0.78	0.73	-0.89	0.73	0.93	-0.73	0.3	0.78	0.83	0.28	-0.27
Depreciation And Amortization	0.59		-0.6	-0.07	0.77	0.79	-0.16	0.2	0.2	0.15	-0.32	0.16	0.74	-0.17	0.94	0.2	0.23	0.53	-0.53
Interest Expense	-0.99	-0.6		0.56	-0.94	-0.85	0.72	-0.73	-0.73	-0.68	0.88	-0.69	-0.94	0.73	-0.31	-0.73	-0.79	-0.31	0.3
Selling General Administrative	-0.56	-0.07	0.56		-0.55	-0.63	0.96	-0.89	-0.89	-0.9	0.64	-0.91	-0.51	0.96	0.14	-0.89	-0.88	-0.66	0.65
Total Revenue	0.93	0.77	-0.94	-0.55		0.92	-0.65	0.68	0.68	0.63	-0.71	0.64	0.99	-0.66	0.5	0.68	0.73	0.51	-0.51
Gross Profit	0.85	0.79	-0.85	-0.63	0.92		-0.72	0.74	0.74	0.7	-0.74	0.72	0.88	-0.73	0.61	0.74	0.76	0.69	-0.69
Other Operating Expenses	-0.72	-0.16	0.72	0.96	-0.65	-0.72		-0.95	-0.95	-0.95	0.83	-0.95	-0.61	1.0	0.08	-0.95	-0.96	-0.54	0.53
Operating Income	0.78	0.2	-0.73	-0.89	0.68	0.74	-0.95		1.0	1.0	-0.83	1.0	0.64	-0.95	-0.04	1.0	0.99	0.45	-0.44
Net Income From Continuing Ops	0.78	0.2	-0.73	-0.89	0.68	0.74	-0.95	1.0		1.0	-0.83	1.0	0.65	-0.95	-0.04	1.0	0.99	0.44	-0.44
Ebit	0.73	0.15	-0.68	-0.9	0.63	0.7	-0.95	1.0	1.0		-0.8	1.0	0.59	-0.95	-0.08	1.0	0.99	0.45	-0.45
Research Development	-0.89	-0.32	0.88	0.64	-0.71	-0.74	0.83	-0.83	-0.83	-0.8		-0.81	-0.69	0.84	-0.08	-0.83	-0.87	-0.2	0.19
Ebitda	0.73	0.16	-0.69	-0.91	0.64	0.72	-0.95	1.0	1.0	1.0	-0.81		0.6	-0.95	-0.06	1.0	0.99	0.47	-0.46
Cost Of Revenue	0.93	0.74	-0.94	-0.51	0.99	0.88	-0.61	0.64	0.65	0.59	-0.69	0.6		-0.63	0.46	0.65	0.7	0.45	-0.45
Total Operating Expenses	-0.73	-0.17	0.73	0.96	-0.66	-0.73	1.0	-0.95	-0.95	-0.95	0.84	-0.95	-0.63		0.07	-0.95	-0.96	-0.54	0.54
Reconciled Depreciation	0.3	0.94	-0.31	0.14	0.5	0.61	0.08	-0.04	-0.04	-0.08	-0.08	-0.06	0.46	0.07		-0.04	-0.03	0.49	-0.5
Income Before Tax	0.78	0.2	-0.73	-0.89	0.68	0.74	-0.95	1.0	1.0	1.0	-0.83	1.0	0.65	-0.95	-0.04		0.99	0.44	-0.44
Total Other Income Expense Net	0.83	0.23	-0.79	-0.88	0.73	0.76	-0.96	0.99	0.99	0.99	-0.87	0.99	0.7	-0.96	-0.03	0.99		0.43	-0.42
Net Income	0.28	0.53	-0.31	-0.66	0.51	0.69	-0.54	0.45	0.44	0.45	-0.2	0.47	0.45	-0.54	0.49	0.44	0.43		-1.0
Income Tax Expense	-0.27	-0.53	0.3	0.65	-0.51	-0.69	0.53	-0.44	-0.44	-0.45	0.19	-0.46	-0.45	0.54	-0.5	-0.44	-0.42	-1.0

Click cells to compare fundamentals

Heart Test Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Heart Historical Income Statement

About Heart Income Statement Analysis

Heart Test Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Heart Test income statement Correlations

Heart Test Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Heart Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Net Income From Continuing Ops	+ 1.0	Operating Income
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Ebit	+ 1.0	Net Income From Continuing Ops

Income Tax Expense	- 1.0	Net Income
Interest Expense	- 0.99	Net Interest Income
Total Other Income Expense Net	- 0.96	Total Operating Expenses
Total Other Income Expense Net	- 0.96	Other Operating Expenses
Income Before Tax	- 0.95	Total Operating Expenses
Total Operating Expenses	- 0.95	Ebitda